Arcus Biosciences (RCUS) Assets Average (2018 - 2026)

Arcus Biosciences' Assets Average history runs 9 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Assets Average fell 9.11% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 9.11% YoY), while the FY2025 annual figure was $1.1 billion, up 1.96% from the prior year.
• Assets Average was $1.1 billion for Q1 2026 at Arcus Biosciences, up from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.6 billion in Q1 2022 to a low of $1.0 billion in Q3 2025.
• Historically, Assets Average has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average soared 83.64% in 2022, then fell 18.54% in 2023.
• A 5-year view of Assets Average shows it stood at $1.3 billion in 2022, then dropped by 15.14% to $1.1 billion in 2023, then rose by 7.17% to $1.2 billion in 2024, then fell by 13.76% to $1.1 billion in 2025, then advanced by 1.09% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.